Don’t miss – Page 3 – Endpoints News

SIGN UP

ViiV drives new corporate coalition including Uber, Tinder and Walmart, aimed at ending HIV

Last week

Pfizer and Roivant team up again for another 'Vant', setting up anti-inflammatory showdown with Prometheus

Last week

As competitors near FDA goalpost, Roche spells out its repeat Alzheimer's setback

Last week

SQZ Biotech slashes headcount by 60% as founder/CEO hits exit — while Synlogic lays off 25%

Last week

Eli Lilly’s Alzheimer’s drug clears more amyloid early than Aduhelm in first-ever head-to-head. Will it matter?

Last week

Merck sues Johns Hopkins for licensing Keytruda patents in secret and in conflict with research collaboration

Last week

BioNTech bets on difficult STING field via small molecule pact with a Polish biotech

Last week

Updated: Catalent to cut about 600 jobs in Indiana, Maryland and Texas

Last week

Jim Wilson biotech iECURE gets fresh $65M to push pediatric liver disease gene therapy into the clinic

Last week

Sana, Codexis lay off staff, reshuffle pipeline in bid to focus cell therapy, enzyme engineering work

Last week

Horizon Therapeutics in takeover talks with Amgen, J&J, Sanofi as potential buyers

Last week

GSK physician survey finds lupus patients at increased risk for organ damage

Last week

MarketingRx roundup: Pfizer, BioNTech re-up iHeartRadio holiday sponsorship; WHO renames monkeypox to 'mpox'

Last week

Bristol Myers scraps gene therapy deal with uniQure for cardiovascular diseases

Last week

Viatris withdraws accelerated approval for topical antimicrobial 24 years later

Last week

Mirum discontinues PhIIb 'Ohana' study in pregnancy setting

Last week

Cajal Neuroscience launches with $96M Series A, tackling Alzheimer's and Parkinson's

Last week

Updated: Roche pulls PD-L1 blockbuster's accelerated approval in bladder cancer

Last week

Post-Brexit UK trade report shows 'worrying' signs for life sciences

Last week

Merck's latest 'Why Vaccines' campaign seeks to better inform vaccine-hesitant moms

Last week

Industry groups, CVS pick apart FDA's proposed pathway for generics to carve out OTC indications

Last week

Fourth accelerated approval in Duchenne? Sarepta gets priority review for gene therapy amid FDA scrutiny

Last week

Nearly a year after his SPAC combines with EQRx, Eli Casdin resigns from board

Last week

Lilly joins in expanded Series A round for BeiGene-partnered mRNA biotech

Last week

First page Previous page 1 234 5 6 Next page Last page